I would say that what is missing from those reports is an acknowledgement of the most important thing with mefloquine and that is that the use of the drug must be discontinued at the onset of psychiatric symptoms. It is this critical warning that I think has been ignored and that has still not been acknowledged by Canadian officials.
On November 9th, 2023. See this statement in context.